Sie sind auf Seite 1von 2

Imaging & Modelling for Optimized Translational Research

Reaching Accurate Stop/Go Decisions Imaging Biomarkers Successfully Applying Predictive Tools

es le ly vid ab on o in x e pr ta bo Th hat sus ol t t a to en ith ted ev w sla u n yo tra

28 30 November 2011 | Dorint Hotel, Potsdam, Germany


Meet the following specialists: Dr. Richard Luke, Principal Scientist, Astrazeneca Dr. Michael Merz, Director Clinical Research, Novartis International AG Dr. Heiko G. Niessen, Clinical Imaging, Global Department of Translational Medicine, Boehringer Ingelheim Pharma GmbH & Co. KG Prof. Stephen Williams, Imaging Science and Biomedical Engineering University of Manchester Prof. Martin Wehling, Managing Director, Institute for Experimental & Clinical Pharmacology University of Heidelberg Dr. Jrg Knig, Laboratory Head, Institute of Experimental and Clinical Pharmacology and Clinical Toxicology, Friedrich-Alexander-University Erlangen-Nrnberg Dr. Kaye Williams, Group Leader Hypoxia and Therapeutics, University of Manchester Dr. Detlef Stiller, Head of In-VivoImaging, Target Discovery Research, Boehringer Ingelheim Pharma, GmbH & CO.KG Dr. Stefanie Reif, Modelling & Simulation Senior Expert, Bayer Pharma AG Dr. Clemens Gnther, Director, Head of Global Preclinical Development, Intendis GmbH Dr. Maciej J. Zamek-Gliszczynski, Drug Disposition, Lilly Research Laboratories, Eli Lilly and Company
To Register | T +49 (0)30 20 91 33 30 |

Better plan your proof-of-concept for a successful translation by learning more on the latest and most innovative methods of imaging biomarkers Learn more about the latest imaging techniques for monitoring disease progression by strategically applying and combining FLT/FDG-PET and MRI Optimize your ROI by designing an adaptive clinical trial and by performing an attrition analysis in the early stages Improve the integration of predictive measures into your trial design by identifying and avoiding toxicological risks Gain new ideas about how to standardize translational methods and develop your own translational tool box

Highlight Speakers:
Professor Martin Wehling, Managing Director, Institute for experimental & Clinical Pharmacology, University of Heidelberg Dr. Detlef Stiller, Head of in-vivo Imaging lab, Target Discovery Research, Boehringer Ingelheim Pharma, GmbH & CO.KG

Join our informative evening workshops:


A | Magnetic resonance neuro-imaging as a translational tool in drug discovery B | Preclinical-to-clinical and in vitro-to-in vivo translation of transport-mediated/limited drug absorption, distribution and excretion C | Single and multiple-transfected cell lines for the analysis of transporter-mediated drug-drug interactions D | Interactive graphical exploration of safety data enhancing signal detection and understanding
Researched and developed by Supported by

Media Partners

F +49 (0)30 20 91 32 10

E info@iqpc.de

www.clinical-translation.de/web

up Bi to rd 3 16 s if 20 Se yo ,- w pt u it em bo h o be ok ur r 2 by Ea 01 th rly 1! e

Sa v

Imaging & Modelling for Optimized Translational Research


28 30 November 2011 | Dorint Hotel, Potsdam, Germany

Sponsorship
We have a variety of packages available to suit your requirements. For all Sponsorship and Exhibition opportunities call Florian Wallner: +49 (0)30 20 91 32 75 or email florian.wallner@iqpc.de.

By joining the conference you will learn how to ... Strategically apply the latest imaging techniques for monitoring disease progression and combining such as FLT/FDG-PET and MRI Improve the integration of predictive measures into your trial design by identifying and avoiding toxicological risks according to lessons-learnt in AstraZeneca Optimize your ROI, save time and money and avoid high attrition rates by better designing your preclinical studies Improve your proof-of-concept by learning more about the latest and most innovative methods of imaging biomarkers Successfully plan physiologically-based PK models and technologies, considerably enhancing your prediction, by understanding better the pros and cons of different modelling techniques Do not miss the opportunity to network, brainstorm and learn more!

Who will you meet?


International pharmaceutical and biotech companies Job function: Directors Managers Global Heads Senior scientists Researchers Departments: Translational Research DMPK PKPD ADME Biomarker Research Toxicity Safety Modelling Imaging Industries: Pharma Biotech

Translational medicine is still in its infancy, and needs careful development both as a generic science and in concrete projects. Professional conferences are a great way to spur a constructive discussion on the way to finding a sustainable translational tool box
Conference Chairman: Prof. Martin Wehling, Managing Director, Institute for Experimental & Clinical Pharmacology, University of Heidelberg

CRO's Translational Research Tool Manufacturer Solution Provider for Screening Systems, Imaging Systems, Modelling Technologies, Testing Others

Download Center
The purpose of the download center is to provide you with relevant content to enhance your knowledge of current trends and industry news. All content is 100% complimentary, easy to download, and current. Featuring live podcast interviews which you can stream on your computer or portable device, up-to-date news from local and international sources, industry whitepapers, and other relevant content the download center is your online portal to expand your knowledge and add value to your business. We encourage your feedback and participation, for all comments or enquiries please contact us on +49 (0)30 20 91 32 74 or eq@iqpc.de.

For further information


please visit our website www.clinical-translation.de/ web or contact us on +49 (0)30 20 91 32 74 or email eq@iqpc.de.

Get free white papers, articles and much more! www.clinical-translation.de/web


IQPC provides business executives around the world with tailored practical congresses, large scale events, topical seminars and in-house training programs, keeping them upto-date with industry trends, technological developments and the regulatory landscape. IQPCs large scale congresses are market leading must attend events for their respective industries. IQPC produces more than 1,500 events annually around the world, and continues to grow. Founded in 1973, IQPC now has offices in major cities across 5 continents including: Berlin, Dubai, London, New York, So Paulo, Singapore, Stockholm, Sydney and Toronto. IQPC leverages a global research base of best practices to produce an unrivalled portfolio of congresses. www.iqpc.de

The quick link for your smartphone

To Register

+49 (0)30 20 91 33 30

+49 (0)30 20 91 32 10

info@iqpc.de

www.clinical-translation.de/web

Das könnte Ihnen auch gefallen